Conditions: Pneumonia, Bacterial Community-acquired
Keywords: pneumonia ceftaroline community-aquired
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 12
Healthy volunteers: no

Brief summary:
This study will further analyze the use of ceftaroline for CABP and compare its potential to eradicate bacterial pathogens to standard fluoroquinolone therapy. The enhanced spectrum of ceftaroline compared to levofloxacin may be further highlighted from this investigation.

Detailed description:

Arms:
arm 1: Pharmacodynamics arm 2: Pharmacodynamics

Interventions: intervention 1: Ceftaroline intervention 2: Levofloxacin
Intervention descriptions: intervention 1: 600 mg Q12h intervention 2: 750 mg QD

Protocol document: